Identificação
Identificação pessoal
- Nome completo
- Joana Paiva Gomes Miranda
Nomes de citação
- Miranda, Joana P
Identificadores de autor
- Ciência ID
- 001A-6278-C231
- ORCID iD
- 0000-0002-7804-4068
- Researcher Id
- J-3698-2013
- Scopus Author Id
- 57190280223
Endereços de correio eletrónico
- jmiranda@ff.ul.pt (Profissional)
- jmiranda@ff.ulisboa.pt (Profissional)
Moradas
- Advanced cell models for predictive toxicology & cell-based therapies Laboratory- imed.ULisboa, University of Lisbon. Av. Prof. Gama Pinto, 1649-003 , Lisboa, Lisboa, Portugal (Profissional)
- Faculty of Pharmacy, University of Lisbon | Av. Professora Gama Pinto, 1649-003, Lisbon, Lisbon, Portugal (Profissional)
Websites
- https://imed.ulisboa.pt/labs/joana-miranda-lab/ (Profissional)
Domínios de atuação
- Ciências Médicas e da Saúde - Biotecnologia Médica - Tecnologias que envolvem a Manipulação de Células,Tecidos,Órgãos ou todo o Organismo
- Ciências Médicas e da Saúde - Biotecnologia Médica - Diagnóstico e Terapias de Base Genética
- Ciências Médicas e da Saúde - Biotecnologia Médica - Biotecnologia Aplicada à Saúde
- Ciências Médicas e da Saúde - Medicina Básica - Toxicologia
- Ciências Médicas e da Saúde - Medicina Básica - Farmacologia e Farmácia
- Ciências Médicas e da Saúde - Medicina Clínica - Gastrenterologia e Hepatologia
Idiomas
Idioma | Conversação | Leitura | Escrita | Compreensão | Peer-review |
---|---|---|---|---|---|
Inglês | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | |
Francês | Utilizador elementar (A1) | Utilizador independente (B1) | Utilizador independente (B1) | Utilizador elementar (A1) | |
Português (Idioma materno) | |||||
Galego | Utilizador independente (B1) | Utilizador proficiente (C1) | Utilizador elementar (A1) | Utilizador independente (B1) |
Formação
Grau | Classificação | |
---|---|---|
2023
Concluído
|
Pharmacy (Título de Agregado)
Especialização em Toxicology
Universidade de Lisboa Faculdade de Farmácia, Portugal
"3D Liver Models for Drug Metabolism and Toxicology Studies" (TESE/DISSERTAÇÃO)
|
|
2020/09/01 - 2021/07/31
Concluído
|
Pedagogia do Ensino Superior | Pedagogy in Higher Education (Pós-Graduação)
Universidade de Lisboa Instituto da Educação, Portugal
|
20 out of 20 |
2015
Concluído
|
SafeSciMET course 2.2: Regulatory Requirements and Guidelines (Pós-Graduação)
IMI (Innovative Medicines Initiative), Luxemburgo
|
|
2014
Concluído
|
Certification on Animal Experimentation (Pós-Graduação)
Federation for Laboratory Animal Science Associations (FELASA), Reino Unido
|
|
2009
Concluído
|
Genetic Toxicology and Toxicogenomics Course (Pós-Graduação)
Genetics Department from NOVA Medical School, Portugal
|
19/20 |
2006/02/06
Concluído
|
Biochemistry (Doutoramento)
Especialização em Biochemistry
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
"Identification and Characterization of Immunodominant Proteins of Theileria Uilenbergi to Be Used in the Diagnosis of Ovine
Theileriosis in China" (TESE/DISSERTAÇÃO)
|
|
2006
Concluído
|
MBI-training Course: Stem Cell and Regenerative Medicine Bioprocessing (Pós-Graduação)
Advanced Centre for Biochemical Engineering, University College London (UCL), Reino Unido
|
|
2000
Concluído
|
Biologia Microbiana e Genetica/ Microbiology and Genetics (Licenciatura)
Universidade de Lisboa Faculdade de Ciências, Portugal
"Cytogenetic Study of Squamous Cell and Basal Cell Carcinomas" (TESE/DISSERTAÇÃO)
|
15/20 |
Percurso profissional
Ciência
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2010 - Atual | Investigador principal (carreira) (Investigação) | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal | ||
2016/12 - 2018/02 | Investigador Auxiliar (carreira) (Investigação) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2014/09 - 2016/11 | Pós-doutorado (Investigação) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2009/07 - 2014/06 | Investigador Auxiliar (carreira) (Investigação) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2006/03 - 2009/06 | Pós-doutorado (Investigação) | Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal |
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal |
Docência no Ensino Superior
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2023/11/01 - Atual | Professor Associado (Docente Universitário) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2018/02/01 - 2023/07/30 | Professor Auxiliar (Docente Universitário) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2014/09 - 2018/01/31 | Professor Auxiliar Convidado (Docente Universitário) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Cargos e Funções
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2019/10 - Atual | Board Member | Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC), Portugal |
2019/02 - Atual | President of the Finance Committee | Portuguese Society of Pharmacology (SPF), Portugal |
2016/02 - Atual | Co-Coordinator of the Portuguese ERT (European Registered Toxicologist) | EUROTOX, Portugal |
Outros
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2016/02 - 2019/01 | Coordinator of the Toxicology Section | Portuguese Society of Pharmacology (SPF), Portugal |
Portuguese Society of Pharmacology (SPF), Portugal | ||
2007/11 - 2007/11 | Visiting Pos-Doc Fellow | Pharmacelsus Gmbh, Alemanha |
Pharmacelsus Gmbh, Alemanha | ||
2006/09 - 2006/10 | Visiting Pos-Doc Fellow | Charité Medicine University of Berlin, BCRT Institute, Alemanha |
Charité Medicine University of Berlin, BCRT Institute, Alemanha | ||
2001/01 - 2006/02 | PhD student (SFRH/BD/6494/2001) - Biomolecular diagnostics/Biossensor Laboratory | Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal |
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal | ||
2005/04 - 2005/05 | Visiting PhD student | Lanzhou Veterinary Research Institute, China |
Lanzhou Veterinary Research Institute, China | ||
2003/03 - 2005 | PhD student (SFRH/BD/6494/2001) | Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften, Alemanha |
Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften, Alemanha | ||
2002/04 - 2002/05 | Visiting PhD student | Onderstepoort Veterinary Institute, África do Sul |
Onderstepoort Veterinary Institute, África do Sul | ||
2001 - 2001 | Junior researcher - Biomolecular diagnostics/Biossensor Laboratory | Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal |
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal | ||
1999/01 - 2000/12 | Junior researcher - Cytogenetics and Cytometry Laboratory - Solid Tumours section | Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal |
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal |
Projetos
Bolsa
Designação | Financiadores | |
---|---|---|
2023 - 2028 | EASL-DHILI: Drug and Herbal & Dietary Supplement-induced Liver Injury (DHILI) Consortium
EASL
Investigador
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
European Association for the Study of the Liver |
2022/12/01 - 2026/11/30 | Halt-chRONic INflammation: Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (nonalcoholic
steatohepatitis) transition to inform early prevention and treatment strategies
101095679
Co-Investigador Responsável (Co-IR)
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
Horizon 2020
Em curso
|
2021 - 2023 | Ner-ib - NER Inhibitors: Enhancing the Efficacy of Platinum-Based Therapy in Non-Small Cell Lung Cancer
NER-ib
Investigador
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
Fundação Champalimaud |
2018/10 - 2022 | EXOther: Understanding the underlying mechanisms by which mesenchymal stem cells promote liver regeneration: the specific
role of exosomes
PTDC/MED-TOX/29183/2017
Investigador responsável
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia |
2016/01 - 2020/12 | EXO-UCX: The use of exosomes derived from umbilical cord tissue mesenchymal stromal cells (UCX) for the treatment of open
cutaneous wounds.
TUBITAK/003/2014
Investigador responsável
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
FCT/TUBITAK Fundação para a Ciência e a Tecnologia |
2018 - 2019 | 3D-PsoPatch: 3D printing-based technology using mesenchymal stem cells for personalized psoriasis therapy
Investigador responsável
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa |
2016/12 - 2018/01/31 | IF2015 | Understanding the underlying mechanisms of mesenchymal stem cells in liver regeneration: the specific role of exosomes
IF/00846/2015
Investigador responsável
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2016 - 2017 | EXO-WOUND: The use of exosomes derived from hnMSCs for improving regeneration of cutaneous wounds
UID/DTP/04138/2013
Investigador responsável
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa
Concluído
|
2015 - 2017 | TrImmuR: Triggering a specific immune response against cancer - a strategy for primary and metastatic tumor treatment
LPCC-NRS/Terry Fox
Orientador
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Liga Portuguesa Contra o Cancro |
2014/03 - 2016 | PrimeUCX: Priming of Mesenchymal Stromal Cells from the Umbilical Cord Tissue (UCX®) as a Means of Incrementing Their Therapeutic
Potency for Rheumatoid Arthritis
EXPL/DTP-FTO/0308/2013
Investigador
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia, I.P. |
2013/03 - 2015/09 | NanoPoliBiofilm: Polymeric therapeutic nanoparticles containing an antimicrobial agent: new opportunities for the development
of anti-biofilm agents to treat prosthetic joint infections.
EXCL/CTM-NAN/0166/2012
Investigador
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia, I.P. |
2011/02 - 2015/07 | Hep-Dif: Development of 3D culture models for human ucmMSC-derived hepatocytes for predictive toxicology and cell therapy
PTDC/SAU-TOX/110457/2009
Investigador responsável
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia, I.P. |
2011/02 - 2015 | NEV: Bioactivation routes of the anti-HIV drug Nevirapine: identification of reactive metabolites and mutagenic potential
PTDC/QUI-QUI/113910/2009
Investigador
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia, I.P. |
2013/11 - 2014/11 | NewTricks: TeachIng an olD drug nEw tricks: re-profiling An anti-HIV drug as an HDL modulator
EXPL/DTP-FTO/0204/2012
Investigador
NOVA Medical School - Faculdade de Ciências Médicas, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Fundação para a Ciência e a Tecnologia, I.P.
Concluído
|
2010/02 - 2013/07 | Acrylamide: Biomarkers of dietary acrylamide exposure: human toxicological relevance
PTDC/SAU-OSM/105572/2008
Investigador
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
NOVA Medical School - Faculdade de Ciências Médicas, Portugal |
Fundação para a Ciência e a Tecnologia, I.P.
Concluído
|
2005 - 2010 | Vitrocellomics: Reducing Animal Experimentation in Preclinical Predictive Drug Testing by Human Hepatic in vitro Models Derived
from Embryonic Stem Cells
LSHB-CT-2006-018940
Bolseiro de Pós-Doutoramento
Instituto de Biologia Experimental e Tecnológica, Portugal
|
European Commission
Concluído
|
2000 - 2005 | ADDAV: Molecular and immunological characterization of merozoite antigens and their encoding genes of a Theileria species
highly pathogenic for small ruminants in China: application for the development of diagnostic tools and a vaccine
ICA4-2000-30028
Bolseiro de Doutoramento
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
European Commission |
Produções
Publicações
Artigo em revista |
|
Capítulo de livro |
|
Poster em conferência |
|
Resumo em conferência |
|
Tese / Dissertação |
|
Propriedade Intelectual
Patente |
|
Outros
Outra produção |
|
Atividades
Apresentação oral de trabalho
Título da apresentação | Nome do evento Anfitrião (Local do evento) |
|
---|---|---|
2023/10/13 | Stem cell-derived hepatocyte-like cells recapitulate cues of insulin resistance progression | ETRS & SPCE-TC 2023 Joint Annual Meeting
European Tissue Repair Society/Portuguese Society of Stem Cells and Cell Therapies (Coimbra, Portugal)
|
2023/06/24 | DHILI Consortium: Interactions with EUROTOX. | EASL Liver Congress 2023
European Association for the Study of the Liver (Vienna, Áustria)
|
2023/06/23 | Exosomes derived from MSCs preconditioned with IFN-gamma and TNF-a show improved immunosuppressive and pro-regenerative effects for chronic wounds. | 2nd Meeting of the Portuguese Network on Extracellular Vesicles
Nova Medical School (Lisbon, Portugal)
|
2023/02/03 | Pro-inflammatory stimuli with INF-gamma and TNF-a promotes immunosupressive and tissue regenerative effects of MSC-derived exosomes | LIII Reunião da Sociedade Portuguesa de Farmacologia/XLI Reunião de Farmacologia Clínica/XXII Reunião de Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2023/02/03 | Preconditioning MSCs with inflammatory stimuli as a promising therapeutic strategy towards neuroinflammation-mediated diseases. | LIII Reunião da Sociedade Portuguesa de Farmacologia/XLI Reunião de Farmacologia Clínica/XXII Reunião de Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2023/02/03 | Exosomes derived from mesenchymal stem cells primed with hepatic SOS signals carry pro-regenerative cargo | LIII Reunião da Sociedade Portuguesa de Farmacologia/XLI Reunião de Farmacologia Clínica/XXII Reunião de Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2023/02/03 | Impairment of migration and invasion of non-small cell lung cancer cells by MnTnBuOE-2-PyP5+ alone and combined with cisplatin | LIII Reunião da Sociedade Portuguesa de Farmacologia/XLI Reunião de Farmacologia Clínica/XXII Reunião de Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2023/01/25 | Cell Culture - Basic Procedures | Encontro da Sociedade Portuguesa de Farmacêuticos Hospitalares e dos Cuidados de Saúde (SPFHCS)
Faculty of Pharmacy, University of Lisbon (Lisbon, Portugal)
|
2022/10/21 | The secretome cargo of human MSCs: players in intercellular communication and immunomodulation | 5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V)
MIMIC-V (Izmir, Turquia)
|
2022/07/05 | Towards a microphysiological stem cell-based hepatic in vitro model for studying insulin signaling pathway | 13th iMed.ULisboa Postgraduate Students Meeting
Faculty of Pharmacy, University of Lisbon (Lisbon, Portugal)
|
2022/04/20 | Cell Culture – Basic Procedures | Encontro da Sociedade Portuguesa de Farmacêuticos Hospitalares e dos Cuidados de Saúde (SPFHCS)
Faculty of Pharmacy, University of Lisbon (Lisbon, Portugal)
|
2022/02/11 | Impact of the SOD mimic MnTnHex-2-PyP5+ and its combination with cisplatin in non-small cells lung cancer cells in vitro | LII Reunião anual da Sociedade Portuguesa de Farmacologia (SPF)/XL Reunião de Farmacologia Clínica/XXI Reunião de Toxicologia
Portuguese Society of Pharmacology (Porto, Portugal)
|
2022/02/10 | Design and fabrication of a microfluidic device for culturing stem cell-derived HLCs for in vitro toxicology | LII Reunião anual da Sociedade Portuguesa de Farmacologia (SPF)/ XL Reunião de Farmacologia Clínica/XXI Reunião de Toxicologia
Portuguese Society of Pharmacology (Porto, Portugal)
|
2022/02/09 | The Secretome of Mesenchymal Stem Cells Ameliorates APAP-induced Hepatic Injury | LII Reunião anual da Sociedade Portuguesa de Farmacologia (SPF)/ XL Reunião de Farmacologia Clínica/XXI Reunião de Toxicologia
Portuguese Society of Pharmacology (Porto, Portugal)
|
2022/02/09 | Exploring the modulation of the MSC secretome towards improved skin regeneration in cutaneous lupus erythematosus | LII Reunião anual da Sociedade Portuguesa de Farmacologia (SPF)/ XL Reunião de Farmacologia Clínica/XXI Reunião de Toxicologia
Portuguese Society of Pharmacology (Porto, Portugal)
|
2021/05/21 | Research in cell therapies | 2º Encontro da SPFCS - Advanced Therapy Medicinal Products: O papel da Farmácia hospitalar no sucesso da implementação das
ATMP.
Portuguese Society of Healthcare Pharmacists (SPFCS) (Leiria, Portugal)
|
2021/03/26 | Advanced Cell Culture Models: The use of 3D cultures in in vitro toxicology and regenerative medicine | iMed.ULisboa Seminars: Promoting health by addressing the disease
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa (Lisbon, Portugal)
|
2021/03/10 | How to Grow Your Cells? - In Vitro Cultures | VI Semana da Bioengenharia
Instituto Superior Técnico, Lisbon University (Lisbon, Portugal)
|
2021/02/18 | Glucagon induces a more periportal phenotype in hepatocyte-like cells | LI Reunião anual da Sociedade Portuguesa de Farmacologia (SPF)/XXXIX Reunião de Farmacologia Clínica/XX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Lisboa, Portugal)
|
2021/02/18 | Metabolism of pentedrone and methylone in HLCs: an enantioselectivity approach | LI Reunião anual da Sociedade Portuguesa de Farmacologia (SPF)/XXXIX Reunião de Farmacologia Clínica/XX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Lisboa, Portugal)
|
2021/02/17 | The secretome of mesenchymal stem cells modulates doxorubicin-induced cytotoxicity | LI Reunião anual da Sociedade Portuguesa de Farmacologia (SPF)/XXXIX Reunião de Farmacologia Clínica/XX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Lisboa, Portugal)
|
2020/03/04 | Towards liver-on-a-chip: the role of hepatocyte-like cells in a physiologically relevant model | 3D3C: Towards a new vista of in-vitro 3-dimensional organization and cell to cell communication
3DCellFit Cost Action, at Hebrew University (Jerusalem, Israel)
|
2020/02/07 | Development of a physiologically relevant hepatic culture medium for the maintenance of a stem-cell derived hepatic in vitro model | L Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVIII Reunião de Farmacologia Clínica/XIX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2020/02/07 | Anti-tumoral potential of scorpionates | L Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVIII Reunião de Farmacologia Clínica/XIX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2020/02/07 | Hepatocyte-like cells as a model for hepatotoxicity studies | L Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVIII Reunião de Farmacologia Clínica/XIX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2020/02/07 | APE1 redox inhibitor E3330 as a potentiator of cisplatin therapy in non-small cell lung cancer | L Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVIII Reunião de Farmacologia Clínica/XIX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2020/02/06 | The secretome of MSC 3D cultures: therapeutic role of exosomes for cutaneous wound healing | L Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVIII Reunião de Farmacologia Clínica/XIX Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2019/10/11 | Delivery of exosomes derived from 3D-cultured human neonatal mesenchymal stromal cells improves cutaneous wound healing | 11th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC)
Portuguese Society for Stem Cells and Cell Therapies (Lisbon, Portugal)
|
2019/10/02 | Anticancer properties of thymoquinone in 786-O renal cancer cells | Meeting Personalized Nutrition in aging society: redox control of major age-related diseases
NutRedOx network (COST Action CA16112) (Lisbon, Portugal)
|
2019/07/08 | The role of a SOD mimic on renal cancer: from etiology to progression | Encontro Ciência 2019
(Lisbon, Portugal)
|
2019/06 | 3D Hepatic in vitro Models as Tools for Toxicity Studies | ToxOmics2019 meeting
Instituto Nacional de Saúde Doutor Ricardo Jorge (Lisbon, Portugal)
|
2019/05 | Advanced Cell Culture Models: The use of 3D cultures in in vitro toxicology and regenerative medicine | Advanced Cell Culture Collaborative Meeting
(Cape Town, África do Sul)
|
2019/04/27 | Human umbilical cord tissue mesenchymal stem cell (UCX®) exosomes as novel modulators of innate immunity | International Molecular Immunology & Immunogenetics Congress IV (MIMIC IV)
Turkish Society of Immunology (TSI) (Bursa, Turquia)
|
2019/04 | Modulation of cancer cell migration by redox-active compounds | Mechanobiology of Migrating Cells: From Basic Science to the Clinic
EuroCellNet (COST Action CA15214) (Coimbra, Portugal)
|
2019/03/13 | Culturing hepatocytes-like cells in microfluidic devices: a new tool for drug discovery, disease modelling and toxicology | Workshop 2019: Cells communicate! (COST Action CA16119 CellFit)
(Belgrade, Sérvia)
|
2019/02/06 | The secretome of 3D-cultured MSCs alleviates experimental rheumatoid arthritis symptoms | XLIX Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVII Reunião de Farmacologia Clínica/XVIII Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Porto, Portugal)
|
2019/02/06 | Studying hepatocyte-like cells in microfluidic devices: a new tool for drug discovery, toxicology and disease modelling | XLIX Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVII Reunião de Farmacologia Clínica/XVIII Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Porto, Portugal)
|
2019/02/06 | Anticancer activity of thymoquinone in human renal cancer cells | XLIX Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVII Reunião de Farmacologia Clínica/XVIII Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Porto, Portugal)
|
2019/01/25 | The secretome cargo of human neonatal MSCs: players in intercellular communication and wound healing | Chemistry Biology Cross Talks 2019
Academia das Ciências de Lisboa (Lisbon, Portugal)
|
2018/10/02 | Priming hnMSCs’ secretome using 3D spheroid cultures for the treatment of cutaneous wounds | 2nd Annual Meeting in vitro 3-D total cell guidance and fitness (COST Action CA16119 CellFit): “Cellular communication in
3D”
(Hvar Island, Croácia)
|
2018/10 | Alternative in vitro systems in toxicology: usefulness of 3D hepatic models | ICOETOX 2018
(Matosinhos, Portugal)
|
2018/07/24 | Exploring umbilical cord tissue-derived mesenchymal stem cells for the treatment of impaired wounds | 10th iMed.ULisboa Postgraduate Students Meeting & 3rd i3DU Meeting
Faculty of Pharmacy, University of Lisbon (Lisbon, Portugal)
|
2018/04/09 | 3D strategies for improving hnMSC derived hepatocyte-like cells (HLCs) for in vitro toxicology applications | Workshop 3-D cultures and Bioprinting. CellFit CostAction (CA16119)
(Tartu, Estónia)
|
2018/02/05 | Study of the potential therapeutic effect of the mesenchymal stem cells (MSCs) secretome on human mammary cells | XLVIII Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVI Reunião de Farmacologia Clínica/XVII Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2018/02/05 | Evaluating umbilical cord-derived mesenchymal stem cells for the treatment of wounds in diabetic mice | XLVIII Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVI Reunião de Farmacologia Clínica/XVII Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2018/02/05 | Establishment of HLC cultures in microfluidic devices: a tool for studying the metabolic syndrome | XLVIII Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVI Reunião de Farmacologia Clínica/XVII Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2018/02/05 | Aquaporins in the endocrine pancreas: possible targets in obesity-induced inflammation | XLVIII Reunião anual da Sociedade Portuguesa de Farmacologia/XXXVI Reunião de Farmacologia Clínica/XVII Reunião de Toxicologia
(SPF)
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2018 | Personalized medicine: Cell and Gene Therapy | IV Semana da Bioengenharia
Instituto Superior Técnico, Lisbon University (Lisbon, Portugal)
|
2017/09/10 | Improving hepatocyte-like cells (HLCs) derived from hnMSC for Toxicology applications using 3D culture systems | 53rd Congress of the European Societies of Toxicology (EUROTOX)
(Bratislava, Eslováquia)
|
2017/07/13 | The use of exosomes derived from hnMSCs for improving regeneration of cutaneous wounds | 9th iMed.ULisboa and 2nd i3DU Postgraduate Students Meeting
(Lisbon, Portugal)
|
2017/07/13 | Nevirapine bioactivation studies using competent 3D hepatocyte cultures | 9th iMed.ULisboa and 2nd i3DU Postgraduate Students Meeting
Faculty of Pharmacy, University of Lisbon (Lisbon, Portugal)
|
2017/02/02 | The use of human neonatal mesenchymal stem cells-derived hepatocyte-like cells as an approach for studying the metabolic syndrome | XLVII Reunião Anual Da Sociedade Portuguesa De Farmacologia/XXXVI Reunião De Farmacologia Clínica/XVII Reunião De Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2017/02/02 | Global gene expression analysis of extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells | XLVII Reunião Anual Da Sociedade Portuguesa De Farmacologia/XXXVI Reunião De Farmacologia Clínica/XVII Reunião De Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2017/02/02 | 3D in vitro cultures of human hepatocyte-like cells as an alternative model for drug biotransformation studies: nevirapine case study | XLVII Reunião Anual Da Sociedade Portuguesa De Farmacologia/XXXVI Reunião De Farmacologia Clínica/XVII Reunião De Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2017/02/02 | Temporal and Tissue Dependent Effects of EFV Exposure: Implications for its Neurotoxicity | XLVII Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXVI Reunião de Farmacologia Clínica/XVII Reunião de Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2016/02/04 | Towards improved MSC-derived hepatocyte-like cells for drug metabolism: Comparison between spheroid cultures and hollow finer bioreactor | XLVI Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXV Reunião de Farmacologia Clínica/XVI Reunião de Toxicologia
Portuguese Society of Pharmacology (Oporto, Portugal)
|
2016/02/04 | Role of MnTnHEX-2-PyP on the adhesion, migration and invasion of doxorubicin-treated breast cancer cells | XLVI Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXV Reunião de Farmacologia Clínica/XVI Reunião de Toxicologia
Portuguese Society of Pharmacology (Oporto, Portugal)
|
2016/02/04 | Development of 3D breast cancer models for the evaluation of gelatinase inhibition on cell migration | XLVI Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXV Reunião de Farmacologia Clínica/XVI Reunião de Toxicologia
Portuguese Society of Pharmacology (Oporto, Portugal)
|
2016/02/04 | Modulation of paraoxonase-1 by nevirapine: comparison between three in vitro models | XLVI Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXV Reunião de Farmacologia Clínica/XVI Reunião de Toxicologia
Portuguese Society of Pharmacology (Oporto, Portugal)
|
2016 | Triggering a specific immune response against cancer - a strategy for primary and metastatic tumor treatment | Liga da luta contra o cancro, Terry Fox Grant
IPO-FG (Lisbon, Portugal)
|
2015/12/02 | 3D culture models for the maturation of stem cell derived hepatocyte-like cells: spheroid culture and hollow fiber-bioreactor as potential in vitro alternatives for drug metabolism studies | HeMiBio International Symposium: Biology meets technology for liver toxicity testing
(Leuven, Bélgica)
|
2015/10/15 | MSC crosstalk between UCX® and BM-MSCs involves G-CSF signaling and promotes wound healing in vivo | 9th International Meeting of the Portuguese Society for Stem Cells (SPCE-TC)
Portuguese Society for Stem Cells and Cell Therapies (Oeiras, Portugal)
|
2015/10/02 | Effect of MnTnHex-2-PyP on the adhesion and migration of doxorubicin-treated MDA-MB-231 cells | Training Course on Redox Biology in Health and Disease, EUROS, COST Action BM1203
(Alicante, Espanha)
|
2015/07/15 | The effect of epigenetic modifiers on the phenotype of hepatocyte-like cells derived from human neonatal mesenchymal stem cells | 7th iMed.ULisboa Postgraduate Students Meeting
Research Institute for Medicines (Lisbon, Portugal)
|
2015/02/05 | Exploiting conditioned medium derived from 3D cultures of human neonatal mesenchymal stromal cells (UCX®) for skin regeneration | XLV Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXIV Reunião de Farmacologia Clínica/XV Reunião de Toxicologia
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2015/02/05 | Inhibition of APE1 redox function with E3330: effects on the proliferation and migration of MDA-MB-231 breast cancer cells | XLV Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXIV Reunião de Farmacologia Clínica/XV Reunião de Toxicologia
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2015/02/05 | Human neonatal mesenchymal stem cells undergo hepatic differentiation and present metabolic activity over time | XLV Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXIV Reunião de Farmacologia Clínica/XV Reunião de Toxicologia
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2015/02/05 | Nevirapine biotransformation: sex differences in hepatic and intestinal contributions | XLV Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXIV Reunião de Farmacologia Clínica/XV Reunião de Toxicologia
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2015/02/05 | Ochratoxin A-induced cytotoxicity and formation of ROS: effect of a manganese(III) porphyrin with superoxide dismutase mimetic activity | XLV Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXIV Reunião de Farmacologia Clínica/XV Reunião de Toxicologia
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2014/11/13 | Cytotoxicity, genotoxicity and reactive oxygen species production by ochratoxin A in monkey kidney cells | II Jornadas Ibéricas de Toxicologia – Toxicologia Clínica, [CO.O3]
(Covilhã, Portugal)
|
2014/09/22 | Cytotoxicity, genotoxicity and ROS production by ochratoxin A in Vero cells | Spetses Summer School “Biochemical Basis of Healthy Aging”
(Spetses, Grécia)
|
2014/09/22 | Effect of the redox-active complex Cu[15]pyN5 in doxorubicin-treated breast cancer cells | “Biochemical Basis of Healthing Ageing”, SFRR-Europe/IUBMB Advanced Summer School, EUROS, COST Action BM1203
(Spetses, Grécia)
|
2014/02/05 | 3D rat hepatocyte primary cultures as a tool to study Nevirapine metabolism and toxicity | XLIV Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXIII Reunião de Farmacologia Clínica/XIV Reunião de Toxicologia
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2014 | Redox modulation by SOD mimics in renal cancer: from etiology to progression | I Jornadas CBIOS – ECTS-ULHT
(Lisbon, Portugal)
|
2013/09/01 | 3D hepatocyte cultures: a useful tool in the study of Nevirapine bioactivation and toxicity | EUROTOX 2013 (49th Congress of the European Societies of Toxicology)
European Societies of Toxicology (Interlaken, Suiça)
|
2013/05/09 | 3-D suspension cultures of umbilical cord-derived mesenchymal stromal cells (UCX®): preservation of mesenchymal properties and potential for skin regeneration | 8th SPCE-TC
Portuguese Society for Stem Cells and Cell Therapies (Faro, Portugal)
|
2013/02/06 | Development of APE1 Inhibitors As Potential Sensitizing Agents For Chemotherapeutic Drugs | XLIII Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXI Reunião de Farmacologia Clínica/XII Reunião de Toxicologia
Portuguese Society of Pharmacology (Oporto, Portugal)
|
2013/02/06 | Chemotherapy sensitizers for breast cancer: beneficial effects of the redox-active complex Cu[15]pyN5 | XLIII Reunião Anual da Sociedade Portuguesa de Farmacologia/XXXI Reunião de Farmacologia Clínica/XII Reunião de Toxicologia
Portuguese Society of Pharmacology (Oporto, Portugal)
|
2012/09/06 | Beneficial effects of the redox-active complex Cu[15]pyN5 in doxorubicin-treated breast cancer cells | 16th SFRRI Biennial Meeting
(London, Reino Unido)
|
2010/03/23 | Tissue Engineering: 3D cultures oh hepatocytes | III ScienceShops on “Genotóxicos e cancro: novas perspectivas, novos desafios”
Faculty of Pharmacy from the Lisbon University (Lisbon, Portugal)
|
2009/09/19 | Bioengineering long term neuronal and hepatocytes spheroid cultures for pre-clinical research | The 9th Conference on Protein Expression in Animal Cells
( Jackson Hole, Wyoming, Estados Unidos)
|
2008/09/25 | Development of 3D-bioreactor test systems for hepatotoxicity and metabolism studies | 15th International Congress on In vitro Toxicology
(Stockholm, Suécia)
|
2007/05 | Identification and characterization of immunodominant proteins of Theileria uilenbergi to be used in the diagnosis of ovine theileriosis in China | INCOME Meeting "Harmonisation and Distribution of Pathogen Detection and Differentiation Tools"
(Carcavelos, Portugal)
|
2005/06/26 | Identification and Characterization of Merozoite Theileria sp. (China) Antigens | 8th Biennal Conference “Impact of emerging zoonotic diseases on animal health”
(Hanoi, Vietname)
|
2004/07/18 | Identification and characterization of merozoite antigens of Theileria species highly pathogenic for small ruminants in China | IX European Multicolloquium Of Parasitology
(Valencia, Espanha)
|
2002/05/13 | Identification and characterization of different Theileria china antigen/sera preparations from small ruminants | EU Commission and Central Asia International Conference on Ticks and Tick-Borne Diseases
(Tashkent, Usbequistão)
|
2001/10/16 | Antigen characterization and purification of Theileria china infected sera from small ruminants | INCO-DEV Meeting: Hypodermosis and Theileria diseases International Conference
(Lanzhou, China)
|
Orientação
Título / Tema Papel desempenhado |
Curso (Tipo) Instituição / Organização |
|
---|---|---|
2021 - Atual | Supervision of post-doc working on the project: "Understanding the underlying mechanisms of mesenchymal stem cells in liver
regeneration: the specific role of exosomes" (PTDC/MED-TOX/29183/2017)
Orientador de Sérgio José Póvoas Camões
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2022 - 2026 | Tackling non-clinical safety issues: A roadmap for human hepatic differentiation from stem cells
Orientador de Susana Neves
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021 - 2025 | Understanding the underlying mechanisms by which mesenchymal stem cells promote liver regeneration: the specific role of exosomes
Orientador de Ana Serras
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021 - 2025 | Development of G4 DNA-Helicase Interaction Inhibitors
Coorientador de Israa Alakhras Aljnadi
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021 - 2025 | Mesenchymal stem cell secretome: a novel therapeutic opportunity to rescue COVID-19-induced neurodegeneration
Orientador de Catarina Mendes Trigo
|
Pharmacy (Doutoramento)
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2019 - 2023 | Unravelling the therapeutic effect of hnMSCs in an in vitro hepatic disease model of insulin resistance using hepatocyte-like
cells and Kupffer cells
Orientador de Joana Saraiva Rodrigues
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021 - 2022 | Strategies for the modulation of the cargo of exosomes derived from Mesenchymal stem cells
Orientador de Inês Simões
|
Engenharia Biomédica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021 - 2022 | The role of the endocannabinoid system in tissue regeneration
Orientador de Guilherme Pargana
|
Engenharia Biomédica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021 - 2022 | Towards an insulin resistance in vitro model: Modulation of cell culture medium and cell culture conditions a human stem cell-derived
hepatocyte-like cell model
Orientador de Dinis Martins
|
Engenharia Biológica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021/02 - 2021/12 | Exploring the modulation of the MSC secretome towards improved skin regeneration in cutaneous erythematosus lupus
Orientador de Samuel Dargen de Matos Branco
|
Engenharia Biológica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021/02 - 2021/12 | Exploring the potential of MSC secretome to counteract APAP-induced hepatic injury in vitro
Orientador de Daniela Ribeiro
|
Engenharia Biológica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021/06 - 2021/11 | Supervision of visiting student under CA17112 “Pro-Euro Dili Network”; “Advancing in vitro models of DILI: key techniques
for the study of hepatotoxicity in cell cultures"
Orientador de Daniel Di Zeo Sanchez
|
Universidad de Málaga, Espanha
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2020 - 2021 | The potential therapeutic role of neural stem cells secretome in neurodegeneration: a bioenergetic approach
Coorientador de Catarina Roxo
|
Ciências Biofarmacêuticas (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020 - 2021 | Exosomes, Nanovesicles for Targeted Delivery
Coorientador de Ana Isabel Ferreira
|
Química Medicinal e Terapêutica (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020 - 2021 | Towards human insulin resistance in vitro disease modeling using human MSCs
Orientador de Madalena Theriaga Gonçalves
|
Engenharia Biomédica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2020 - 2021 | Microfluidic cell-chip for an in vitro hepatic disease model
Orientador de Sofia Relvas
|
Engenharia Biomédica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2019 - 2021 | Anti-tumoral effects of an Iron and a Cobalt Scorpionate
Orientador de Pedro Miguel da Graça Silva
|
Engenharia Biomédica e Biofísica (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2019 - 2021 | Potential Role of the Neural Stem Cell Secretome in Modulating Neural Injury
Coorientador de Carlos Rafael Lopes
|
Engenharia Biomédica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2018 - 2021 | Supervision of pos-doc working on the project: "Understanding the underlying mechanisms of mesenchymal stem cells in liver
regeneration: the specific role of exosomes" (PTDC/MED-TOX/29183/2017)
Orientador
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2019 - 2020 | Modulating mesenchymal stem cells for personalized psoriasis therapy
Coorientador de Patrícia Filipa Rodrigues Ferreira de Sousa
|
Ciências Veterinárias (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2018 - 2020 | Supervision of post-doc working on the project: "Understanding the underlying mechanisms of mesenchymal stem cells in liver
regeneration: the specific role of exosomes" (PTDC/MED-TOX/29183/2017)
Orientador
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2016 - 2020 | Modulating Mesenchymal Stem Cells to Overcome Impaired Wound Heading
Orientador de Sérgio José Póvoas Camões
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2009 - 2020 | Supervision of more than 20 undergraduate students.
Orientador de more than 20 undergraduate students
|
- (Licenciatura/Bacharelato)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 - 2019 | Inhibition of the redox function of APE1 as a potential strategy to improve the efficacy of cisplatin in non-small cell lung
cancer cells
Coorientador de Rita Manguinhas
|
Ciências Biofarmacêuticas (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015 - 2019 | Aquaporins in metabolic syndrome: new targets for drug discovery
Coorientador de Inês Vieira da Silva
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015 - 2019 | Triggering a specific immune response against cancer – a strategy for primary and metastatic tumor treatment
Coorientador de Pedro Franco Pinheiro
|
Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Lisboa Instituto Superior Técnico, Portugal |
2017/03 - 2018/04 | Supervision of research scholar under the project “The use of exosomes derived from umbilical cord tissue mesenchymal stromal
cells (UCX®) for the treatment of open cutaneous wounds.” (TUBITAK/0003/2014)
Orientador de Joana Rodrigues
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2016 - 2018 | Study of the potential therapeutic effects of the MSC secretome on mammary cancer cells
Orientador de Bernardo Antunes
|
Biologia Evolutiva e do Desenvolvimento (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2015 - 2017 | Cytotoxic study of anthraquinones from Aloe vera
Coorientador de Catarina Correia
|
Universidade de Lisboa Instituto Superior Técnico, Portugal
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal |
2013 - 2017 | Development of three-dimensional umbilical cord-derived mesenchymal stem cell culture for differentiation into hepatocyte-like
cells: a potencial breakthrough in toxicological drug screening
Orientador de Madalena Zincke dos Reis Fernandes Cipriano
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2011 - 2017 | Canine leishmaniosis: the role of hepatocytes and Kupffer cells during Leishmania infantum infection
Coorientador de Maria Armanda Rodrigues
|
Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal
|
2016/04 - 2016/06 | Supervision of visiting student; “Evaluation of the potential of hnMSC condition medium as modulator of cytotoxicity"
Orientador de Mehmet Karaçay
|
Bursa Uludag Üniversitesi, Turquia
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2015 - 2016 | The use of MSC derived hepatocyte-like cells in microfluidics culture systems: an approach for studying the metabolic syndrome
Orientador de Joana Rodrigues
|
Engenharia Biomédica (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2011 - 2016 | Modulation of Base Excision Repair Pathway for Breast Cancer Therapy
Coorientador de Patrícia Guerreiro
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2015 | Effects on Cell Migration and Invasion of Breast Cancer Cell lines in 3D Models upon MMP inhibition
Orientador de Susana Duarte Lopes Mascarenhas Proença
|
Ciências Biofarmacêuticas (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2013/05 - 2014/04 | Supervision of a research scholar under the project “Bioactivation routes of the anti-HIV drug Nevirapine: identification
of reactive metabolites and mutagenic potential.” (PTDC/QUI-QUI/113910/2009)
Orientador de Pedro Pinheiro
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2013 - 2014 | Exploiting hnMSCs 3D cultures conditioned medium for tissue regeneration
Orientador de Sérgio Camões
|
Biologia Evolutiva e do Desenvolvimento (Mestrado)
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2011/12 - 2013/05 | Supervision of a research scholar under the project: “Development of 3D culture models for human ucmMSC-derived hepatocytes
for predictive toxicology and cell therapy.” (PTDC/SAU-TOX/110457/2009)
Orientador de Elysse Filipe
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2012 - 2013 | Optimization of the differentiation process of ucmMSCs into hepatocyte-like cells
Orientador de Alexandra Silva
|
Biologia Evolutiva e do Desenvolvimento (Mestrado)
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2011 - 2012 | Metabolitos fenólicos do fármaco anti-HIV Nevirapina: Mecanismos de bioactivação em culturas 3D de hepatócitos de rato
Orientador de Pedro Pinheiro
|
Engenharia Biológica (Mestrado)
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
Universidade de Lisboa Instituto Superior Técnico, Portugal |
2010 - 2011 | Optimization of low serum human umbilical cord matrix Mesenchymal Stem Cell (ucmMSC) culture for conditioned media preparation:
in vitro and in vivo wound healing applications
Orientador de Elysse Filipe
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
ECBio SA, Portugal |
2010 - 2011 | Exploiting the interplay between cellular redox balance and breast cancer invasiveness (SFRH/BPD/69042/2010)
Coorientador de Ana Sofia Fernandes
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2010 - 2011 | Supervision of post-doc working on the project: "Exploiting the interplay between cellular redox balance and breast cancer
invasiveness" (SFRH/BPD/69042/2010)
Coorientador
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2007 - 2008 | Development of 3D primary cultures of hepatocytes for drug screening
Coorientador de Armanda Rodrigues
|
Animal Cell Technology Unit, ITQB/IBET, Universidade Nova de Lisboa, Portugal
|
2003 - 2004 | Identificação e caracterização de proteínas antigénicas de uma espécie de Theileria patogénica para pequenos ruminantes na
China
Coorientador de Elisabete Nascimento
|
Biosensor/Biomolecular Diagnostic Laboratory, ITQB/IBET, Universidade Nova de Lisboa, Portugal
|
Organização de evento
Nome do evento Tipo de evento (Tipo de participação) |
Instituição / Organização | |
---|---|---|
2012 - Atual | Coordinator of the CBT seminars at iMed.ULisboa (2012)
Outro
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2023/01 - 2023/01 | Organization of the Young Investigators Seminar Series - Cost Action: CA17112 - Prospective European Drug-Induced Liver Injury
Network.
(2023/01 - 2023/01)
Seminário (Membro da Comissão Organizadora)
|
|
2021/10/23 - 2021/10/30 | Coordinator of i-Days: Innovation days - EIT Health (2021/10/23 - 2021/10/30)
Encontro (Membro da Comissão Organizadora)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021/02/17 - 2021/02/19 | Chair/Coordinator of the 51st Meeting of the Portuguese Society of Pharmacology (SPF) – LI Portuguese Society of Pharmacology
(SPF 2021) (2021/02/17 - 2021/02/19)
Congresso (Coorganizador)
|
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal |
2019 - 2019 | Coordinator/Chair of the 11th meeting of the Portuguese society of Stem Cells and Cell Therapy (SPCE-TC) (2019/10/10 - 2019/10/12)
Congresso (Presidente da Comissão Organizadora)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2017/09/10 - 2017/09/13 | Coordinator and meeting chair of the Workshop: “Stem cell systems and 3D technologies: Implementation for in vitro liver toxicology
assessment” (2017/09/10 - 2017/09/13)
Congresso
|
EUROTOX 2017, Eslováquia |
2015/10/10 - 2015/10/10 | Coordinator and meeting chair of the “MSCs Workshop: Towards Cell Based Tolerance-Inducing Therapies” organized under the
frame of the COST Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies - A FACTT (BM1305) (2015/10/10 - 2015/10/10)
Oficina (workshop)
|
|
2015/04 - 2015/04 | Organizer and coordinator of the A FACTT COST meeting (BM1305: Action to Focus and Accelerate Cell-based Tolerance-inducing
Therapies) (2015/04 - 2015/04)
Encontro
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2003/03/31 - 2003/04/10 | Member of the coordination committee of the Workshop “Establishment of tick colonies and tissue cultures of Theileria annulata
for the immunisation against tropical theilerosis” (2003/03/31 - 2003/04/10)
Oficina (workshop) (Membro da Comissão Organizadora)
|
Instituto de Biologia Experimental e Tecnológica, Portugal Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal Universidade de Lisboa Faculdade de Medicina Veterinária, Portugal |
Participação em evento
Descrição da atividade Tipo de evento |
Nome do evento Instituição / Organização |
|
---|---|---|
2023/02/01 - 2023/02/02 | Session Chair: Toxicology I.
Encontro
|
XLXIII Portuguese Society of Pharmacology (SPF)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
2022/03/10 - 2022/03/11 | Session chair: Keynote Lecture - Tissue engineering.
Encontro
|
12th International Meeting of SPCE-TC
Universidade do Minho Faculdade de Medicina, Portugal
|
2022/02/09 - 2022/02/11 | Session Chair: “Molecular and Cellular Therapies I” session
Encontro
|
LII Portuguese Society of Pharmacology (SPF)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2021/10/11 - 2021/10/12 | Training school | Discovery to translation
CA-17112: prospective european drug-induced liver injury network, Reino Unido
|
2021/09/08 - 2021/09/10 | In vitro 3D total Cell Guidance and Fitness - Conference attendance
Conferência
|
The Three Dimensions of CellFit ¿ Achievements, Challenges and Future Prospects
CA-16119 - In vitro 3-D total cell guidance and fitness, Itália
|
2021/02/17 - 2021/02/19 | Session Chair: “Toxicology II Session”
Encontro
|
LI Portuguese Society of Pharmacology (SPF)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/02/17 - 2021/02/19 | Session Chair: Keynote Lecture - Cellular stress responses and prediction of adverse drug responses, Bob Van der Water.
Encontro
|
LI Portuguese Society of Pharmacology (SPF)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/02/01 - 2020/02/05 | Session Chair: Toxicology I Session
Encontro
|
L Portuguese Society of Pharmacology (SPF)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
2019/05/13 - 2019/05/15 | Session Chair of the Plenary lecture: “Outreaching biotechnological enterprises in DILI”
Encontro
|
1st working group meeting of the Pro-Euro Dili COST action (CA17112)
Universidad de Málaga Facultad de Medicina, Espanha
|
2019/03/14 - 2019/03/15 | Training School | Assessment of drug induced liver injury
CA-17112: prospective european drug-induced liver injury network, Espanha
|
2019/02/06 - 2019/02/08 | Session Chair: “Molecular & Cellular Based Therapies Session”
Encontro
|
XLIX Portuguese Society of Pharmacology (SPF)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2018/02/04 - 2018/02/06 | Session Chair: “Toxicology III Session”
Encontro
|
XLVIII Portuguese Society of Pharmacology (SPF)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2017/02/05 - 2017/02/07 | Session Chair: “Toxicology Session”
Encontro
|
XLVII Portuguese Society of Pharmacology (SPF)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
2016/09/04 - 2016/09/07 | Session Chair: “Symposium S05: The H2020 EU-ToxRisk project: a novel flagship program for mechanism-based safety sciences
and risk assessment”
Congresso
|
EUROTOX2016 |
2016/06/27 - 2016/07/08 | Verão na ULisboa 2016 – “Uma viagem pelos Laboratórios da Faculdade de Farmácia”, DCTB/FFUL | Verão na ULisboa 2016 – “Uma viagem pelos Laboratórios da Faculdade de Farmácia”
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2016/03/15 - 2016/03/20 | Descobre a ULisboa 2016 – “Os alimentos e a saúde”, DCTB/FFUL | Descobre a ULisboa 2016 – “Os alimentos e a saúde”
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2016/02/04 - 2016/02/06 | Session Chair: “Cancer Pharmacology Session”
Encontro
|
XLVI Portuguese Society of Pharmacology (SPF)
Universidade do Porto Faculdade de Medicina, Portugal
|
2015/06/29 - 2015/07/10 | Verão ULisboa 2015 – “Uma viagem pelos Laboratórios da Faculdade de Farmácia”, DCTB/FFUL | Verão ULisboa 2015 – “Uma viagem pelos Laboratórios da Faculdade de Farmácia”
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015/02/04 - 2015/02/06 | Session Chair at the XLV Portuguese Society of Pharmacology (SPF)
Encontro
|
XLV Portuguese Society of Pharmacology (SPF)
NOVA Medical School - Faculdade de Ciências Médicas, Portugal
|
2015 - 2015 | Medicines OpenScience 2015 – Participation in an initiative targeted to university students wishing to further explore the research activities at iMed.ULisboa | Medicines OpenScience 2015
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal
|
2014 - 2014 | Ciência Viva 2014 – “Vamos explorar fármacos e tóxicos?”, DCTB/FFUL | Ciência Viva 2014 – “Vamos explorar fármacos e tóxicos?"
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2013/05/26 - 2013/05/30 | Workshop participation | EMBO Workshop on Liver and Pancreas development, function and disease
EMBO, Alemanha
|
2013/05/26 - 2013/05/30 | EMBO workshop attendance
Oficina (workshop)
|
EMBO Workshop on Liver and Pancreas Development, Function and Disease
EMBO, Alemanha
|
2013/05/09 - 2013/05/10 | Session Chair: “Stem Cell Bioprocessing Session”
Encontro
|
8th International Annual Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC)
Universidade do Algarve, Portugal
|
2013/04/12 - 2013/04/13 | VIH/sida e Hepatites víricas | VIH/sida e Hepatites víricas
Direção Científica do Hospital de Santa Maria CHLN-EPE, Portugal
Fundación, Investigación e Educación en Sida, Espanha |
2013 - 2013 | Ciência Viva 2013 – “Vamos analisar medicamentos?”, DCTB/FFUL | Ciência Viva 2013 – “Vamos analisar medicamentos?”
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2008 - 2008 | ITQB Open Day 2008 – "Venha Descobrir a Ciência" | ITQB Open Day 2008 – Venha Descobrir a Ciência
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2006 - 2006 | ITQB Open Day 2006 – "Explorando a Vida: do átomo ao ambiente" | ITQB Open Day 2006 – "Explorando a Vida: do átomo ao ambiente"
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2003 - 2003 | Event participation | Advanced Microbiology and Biotechnology Techniques: Theoretical-Practical Course of Phage Display Technology for the selection
of recombinant antibodies
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2003 - 2003 | Workshop participation
Oficina (workshop)
|
Establishment of tick colonies and tissue cultures of Theileria annulata for the immunisation against tropical theilerosis
Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal
Instituto de Biologia Experimental e Tecnológica, Portugal Universidade de Lisboa Faculdade de Medicina Veterinária, Portugal |
2002/06/03 - 2002/06/07 | Course participation | Course on Proteins Purification
Universidade Nova de Lisboa Departamento de Química, Portugal
|
1999 - 1999 | Course participation | Genetics in Oncology
Universidade de Coimbra Faculdade de Medicina, Portugal
|
Júri de grau académico
Tema Tipo de participação |
Nome do candidato (Tipo de grau) Instituição / Organização |
|
---|---|---|
2022/09/07 | DesinFAST- Self-Disinfecting Paint for Infection Control in Public Spaces
Arguente principal
|
Micaela Querido (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022/02 | Modelling degenerative retinal mechanisms in 3D retinal organoids
Arguente principal
|
Inês Paz Santos (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/12 | Exploring the modulation of the MSC secretome towards improved skin regeneration in cutaneous erythematosus lupus
Arguente
|
Samuel Branco (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2021/12 | Exploring the potential of MSC secretome to counteract APAP-induced hepatic injury in vitro
Arguente
|
Daniela Ribeiro (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2021/09/21 | Enantioselectivity of pentedrone and methylone: enantioresolution by liquid chromatography and in vitro toxicokinetic/toxicodynamic
studies
Arguente principal
|
Bárbara Poleri (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/07 | Towards human insulin resistance in vitro disease modeling using human MSCs
Arguente
|
Madalena Theriaga (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2021/03/22 | Anti-tumoral effects of an Iron and a Cobalt Scorpionate
Orientador
|
Pedro Miguel da Graça Silva (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2021/03/18 | Interplay between adipose-derived stem cells and inflammatory mediators: impact on neurite outgrowth and vascular morphogenesis.
Arguente principal
|
João Vítor Lemos Afonso (Mestrado)
Universidade do Minho Escola de Medicina, Portugal
|
2021/03 | Interplay between adipose-derived stem cells and inflammatory mediators: impact on neurite outgrowth and vascular morphogenesis
Arguente principal
|
João Afonso (Mestrado)
Universidade do Minho Escola de Medicina, Portugal
|
2021/01/27 | Bioenergetic Regulation of Neural Stem Cell Secretome: a Novel Therapeutic Opportunity for Neurodegeneration
Arguente principal
|
Sónia Cristina Rebocho Siquenique (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/12/09 | Modulating mesenchymal stem cells to overcome impaired wound healing
Orientador
|
Sérgio José Póvoas Camões (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/07/23 | Triggering a specific immune response against cancer - a strategy for primary and metastatic tumor treatment
Vogal
|
Pedro Boto Pereira Franco Pinheiro (Doutoramento)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2020/07/02 | Variability in sulfonation capacity in a healthy population
Arguente principal
|
Joana Pinheiro Leite da Anunciação Reis (Outro)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2020/07/02 | Frações de cisteína como marcadores de risco de fibrose em pacientes em diálise peritoneal
Arguente principal
|
Rita Alexandre Coelho (Outro)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2020/01/17 | Development of new chemical entities based on natural scaffolds with therapeutic potential towards age related disorders
Arguente principal
|
Daniel Freitas Chavarria (Doutoramento)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2019/10/17 | Aquaporins in Metabolic Syndrome: New Targets for Drug Discovery
Orientador
|
Inês Margarida Vieria da silva (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/06/21 | TARGETING MITOCHONDRIA OF NEURAL STEM CELLS
FOR NEUROREGENERATION
Arguente
|
MARIA FILIPE CANAS DE MATOS E OLIVEIRA RIBEIRO (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019 | Master thesis juries: Participation in a total of 14 juries
Arguente
|
Participation in 14 juries (Mestrado) |
2017/12 | Effect of a good-manufacturing-practice xeno-free medium on mesenchymal stromal cell properties: Multipotentiality, Immunomodulation
and Recruitment
Arguente principal
|
Arantxa Blázquez Prunera (Doutoramento)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2017/07 | Targeting Hepatocyte Necroptosis to treat Liver Diseases
Arguente
|
Marta Afonso (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2017/06 | Development of three-dimensional umbilical cord-derived mesenchymal stem cell cultures for differentiation into hepatocyte-like
cells: a potential breakthrough in toxicological drug screening
Arguente
|
Madalena Cipriano (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2017/02 | The anti-HIV drug Efavirenz: A challenge on molecular mechanisms of drug associated neurocognitive disorders
Arguente
|
Nádia Grilo (Doutoramento)
NOVA Medical School - Faculdade de Ciências Médicas, Portugal
|
2016/10 | Mesenchymal stem/stromal cell mobilization following immune responses to 3D biomaterials
Arguente principal
|
Hugo Caires (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
Arbitragem científica em conferência
Nome da conferência | Local da conferência | |
---|---|---|
2023/10/11 - 2023/10/13 | 13th International Meeting of SPCE-TC & European Tissue Repair Society Annual Meeting 2023 | Universidade de Coimbra |
2023/02/01 - 2023/02/03 | 53rd Meeting of the Portuguese Society of Pharmacology (SPF 2023) | Faculdade de Medicina da Universidade de Coimbra |
2022/02/09 - 2022/02/11 | 52nd Meeting of the Portuguese Society of Pharmacology (SPF 2022) | Instituto de Ciências Biomédicas Abel Salazar, Porto, PT |
2021/02/17 - 2021/02/19 | 51st Meeting of the Portuguese Society of Pharmacology (SPF 2021) | Faculdade de Farmácia da Universidade de Lisboa |
2019/10/17 - 2019/10/19 | 11th International Meeting of SPCE-TC (Sociedade Portuguesa de Células Estaminais e Terapia Celular) | Faculdade de Farmácia da Universidade de Lisboa |
2019/02/17 - 2019/02/19 | 49th Meeting of the Portuguese Society of Pharmacology (SPF 2019) | Faculdade de farmácia da Universidade de Coimbra |
2018/02/05 - 2018/02/07 | 48th Meeting of the Portuguese Society of Pharmacology (SPF 2018) | Faculdade de Medicina da Universidade de Lisboa |
Arbitragem científica em revista
Nome da revista (ISSN) | Editora | |
---|---|---|
2019 - 2021 | Frontiers in Cell and Developmental Biology (2296-634X) | Frontiers Media SA |
2019 - 2020 | Frontiers in Genetics (1664-8021) | Frontiers Media SA |
Comissão de avaliação
Descrição da atividade Tipo de assessoria |
Instituição / Organização | Entidade financiadora | |
---|---|---|---|
2022 - 2022 | Project Evaluator - Evaluator of project proposals for the Fundação para a Ciência e a Tecnologia (FCT) scholarship program, in the respective panel of "Medicina Clínica e Ciências da Saúde". | Fundação para a Ciência e a Tecnologia, Portugal | Fundação para a Ciência e a Tecnologia |
2020 - 2020 | Project Evaluator - Expert evaluator for the NOW agency, Netherlands
Avaliador
|
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | |
2018 - 2020 | Project Evaluator - Expert evaluator for the ESF agency, France
Avaliador
|
European Science Foundation | |
2014 - 2020 | Project Evaluator - Expert evaluator for the European Commission, H2020 Societal Challenge, Individual Fellowships, Life Sciences Panel (H2020-IF-ST-2014/2015/2016/2017 - LIF panel) | Commission Européenne Représentation au Luxembourg | |
2016 - 2019 | Project Evaluator - Expert evaluator for the P2020 (Portugal 2020), SI I&DT - AAC 33/SI/2015 | ||
2015 - 2019 | Middle-term expert evaluator of Projects funded by the IMI (Innovative Medicines Initiative), IMI2 Call 6: Topic 1 - Development
of Quantitative System Toxicology (QST)
Avaliador
|
IMI (Innovative Medicines Initiative), Luxemburgo | IMI (Innovative Medicines Initiative) |
2018 - 2018 | Project Evaluator - Expert evaluator for the European Commission, H2020 Societal Challenge, H2020-SC1-2019-Two-Stage-RTD
Avaliador
|
Commission Européenne Représentation au Luxembourg, Luxemburgo | Commission Européenne Représentation au Luxembourg |
2018 - 2018 | Project Evaluator - CEDOC pos-doc evaluation panel member | ||
2016 - 2018 | Project Evaluator - Expert evaluator for the European Commission, H2020 Societal Challenge, Individual Fellowships, Life Sciences Panel (H2020-MSCA-ITN-2016/2017- LIF panel). | ||
2017 - 2017 | Middle-term expert evaluator of Projects funded by the European Commission, H2020 Societal Challenge 2 - 2nd and Single stage 2014 evaluations, "Innovative Sustainable and Inclusive Bioeconomy" (H2020-ISIB-2017) | ||
2014 - 2014 | Project Evaluator - Expert evaluator for the European Commission, H2020 Societal Challenge 2 - 2nd and Single stage 2014 evaluations, "Innovative Sustainable and Inclusive Bioeconomy" (H2020-ISIB-2014) | ||
2014 - 2014 | Project Evaluator - Expert evaluator for the Czech-Norwegian Research Programme (CZ09), 2014 (http://www.msmt.cz/vyzkum-a-vyvoj/call-for-proposals-2013-announcement) |
Curso / Disciplina lecionado
Disciplina | Curso (Tipo) | Instituição / Organização | |
---|---|---|---|
2021 - Atual | Novel Challenges in Toxicology (coordinator) | Farmácia (Doutoramento) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2020 - Atual | Stem Cells Technologies (organizer) | Farmácia (Doutoramento) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2019 - Atual | Toxicologia dos Alimentos | Qualidade Alimentar e Saúde (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2018 - Atual | Envelhecimento e doenças crónicas associadas: dos mecanismos moleculares às terapias | Investigação Biomédica (Mestrado integrado) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
2016 - Atual | Toxicologia Geral - theoretical lessons | Mestrado em Qualidade Alimentar e Saúde (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2015 - Atual | Toxicologia - theoretical and laboratory lessons | Mestrado Integrado em Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2014 - Atual | Antioxidantes Naturais e Sintéticos – theoretical lessons | Qualidade Alimentar e Saúde (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2014 - Atual | Biologia e Tecnologia de Células Estaminais | Biologia Evolutiva e do Desenvolvimento | Universidade de Lisboa Faculdade de Ciências, Portugal |
2012 - Atual | Monografia / Estágio (Supervision of a total of 6 students) | Mestrado Integrado em Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2011 - Atual | Química Analítica | Mestrado Integrado em Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2022/09/27 - 2022/09/29 | Coordinator of the 5th Training course COST Action 17-112 Pro-EURO DILI NET: Novel challenges in toxicology | Universidade de Lisboa Faculdade de Farmácia, Portugal | |
2021 - 2022 | Química geral | Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2020 - 2022 | Terapêutica Molecular e Engenharia de Tecidos | Biotecnologia Farmacêutica (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021/10/19 - 2021/10/21 | Coordinator of the 4th Training course COST Action 17-112 Pro-EURO DILI NET: Novel challenges in toxicology | Universidade de Lisboa Faculdade de Farmácia, Portugal | |
2012 - 2021 | Coordinator of the theoretical and practical module “Basic Procedures of Cell Culture” within the Course “Fundamentos de Cultura Celular” | Universidade Lusófona de Humanidades e Tecnologias, Portugal | |
2019/10/10 - 2019/10/11 | Coordinator of the 2nd Training course COST Action 17-112 Pro-EURO DILI NET. Recent Advances on Stem Cell Research and Cell Therapies | (Outros) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2018 - 2019 | Projecto | Ciências da Saúde (Licenciatura) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2016 - 2019 | Toxicologia | Química Farmacêutica e Terapêutica (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2015 - 2019 | Toxicologia - theoretical and laboratory lessons | Licenciatura de Ciências da Saúde (Licenciatura) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2016 - 2018 | Toxicologia Geral - theoretical lessons | Mestrado em Química Farmacêutica e Terapêutica (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2014 - 2018 | Biologia e Tecnologia de Células Estaminais – theoretical lessons | Mestrado em Biologia Evolutiva e do Desenvolvimento (Mestrado) | Universidade de Lisboa Faculdade de Ciências, Portugal |
2010 - 2018 | Biologia Celular - laboratory lessons | Licenciatura de Ciências da Saúde (Licenciatura) | Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Lisboa Faculdade de Psicologia, Portugal Universidade de Lisboa Faculdade de Medicina, Portugal |
2009 - 2018 | Antioxidantes Naturais e Sintéticos - theoretical lessons | Mestrado em Qualidade Alimentar e Saúde (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2010 - 2017 | Projecto (Supervision of a total of 5 students) | Mestrado Integrado em Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2016 - 2016 | Coordinator of the theoretical and practical module “Basic Procedures of Cell Culture” within the Course “Fundamentos de Cultura Celular” | Universidade Lusófona de Humanidades e Tecnologias, Portugal | |
2014 - 2016 | Projecto I/II | Ciências Biofarmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2014 - 2014 | Coordinator of the theoretical and practical module “Basic Procedures of Cell Culture” within the Course “Fundamentos de Cultura Celular” | Universidade Lusófona de Humanidades e Tecnologias, Portugal | |
2012 - 2012 | Coordinator of the theoretical and practical module “Basic Procedures of Cell Culture” within the Course “Fundamentos de Cultura Celular” | Universidade Lusófona de Humanidades e Tecnologias, Portugal | |
2009 - 2012 | Antioxidantes Naturais e Sintéticos – theoretical lessons | Mestrado em Controlo de Qualidade e Toxicologia e dos Alimentos (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2009 - 2011 | Quimica Farmacêutica II – practical lessons | Mestrado Integrado em Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2009 - 2011 | Química Farmacêutica II | Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2005 - 2006 | Biosensors – practical lessons | Engenharia dos Materiais (Mestrado integrado) | Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal |
2002/06/12 - 2002/06/26 | Coordinator of the theoretical and practical module “SDS-PAGE, Western-Blot and ELISA” of the Workshop “Diagnosis and molecular characterization of Theileria sp.” | Lanzhou Veterinary Research Institute, China |
Membro de associação
Nome da associação | Tipo de participação | |
---|---|---|
2013 - Atual | Sociedade Portuguesa de Farmacologia (SPF) | Coordinator of the Toxicology section 2017-2019, President of the Fiscal council since 2019, member since 2013 |
2012 - Atual | Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC) | Board Member |
Membro de comissão
Descrição da atividade Tipo de participação |
Instituição / Organização | |
---|---|---|
2021/09 - Atual | President of the Communication Committee of EUROTOX
Presidente / Vice-presidente
|
European Society of Toxicology (EUROTOX), Bélgica |
2023 - 2027 | Steering Committee member of the "EASL DHILI Consortium - Drug and Herbal & Dietary Supplement-Induced Liver Injury Consortium" | |
2022 - 2026 | Management Committee (MC) member of E.COST CA20140 – “CorEuStem: The European Network for Stem Cell Core Facilities" | |
2021 - 2024 | Management Committee (MC) member of E.COST CA19144 CA20121 – “BenBedPhar: Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases” | |
2020 - 2024 | Management Committee (MC) member of E.COST CA19144 “European Venom Network” | |
2018 - 2022 | Management Committee (MC) member of E.COST CA17112 “Prospective European Drug-Induced Liver Injury Network” | |
2017 - 2021 | Management Committee (MC) member of E.COST CA16119 “CellFit: In vitro 3-D total cell guidance and fitness” | |
2017 - 2021 | Management Committee (MC) member of E.COST CA16113 “CliniMARK: ‘good biomarker practice’ to increase the number of clinically validated biomarkers” | |
2013 - 2017 | Management Committee (MC) and Dissemination Committee member of the E.COST (European Cooperation in Science and Technology) BM1305 “A FACTT: Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies” |
Distinções
Prémio
2023 | Best poster: IFN-gamma and TNF-a preconditioning enhances the MSC's immunosuppressive and tissue regenerative abilities. ETRS
Conference 2023, Coimbra, Portugal.
European Tissue Repair Society, Bélgica
|
2023 | Top 4 Abstract: Exosomes derived from mesenchymal stem cells exposed to hepatic injury signals reveal a distinct protein signature
associated to pro-regenerative effects. 57th Congress of the European Societies of Toxicology, Ljubljana, Slovenia.
European Society of Toxicology (EUROTOX), Bélgica
|
2023 | Best poster: Development of a stem cell-derived hepatocyte-like cell model to study hepatic insulin resistance. iMed.ULisboa
Meeting 2023, Lisbon, Portugal.
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
2023 | Best poster: Exosomes derived from MSCs primed with APAP injury signals reveal a pro-regenerative signature. 2nd PNEV Meeting
2023, Lisbon, Portugal..
Portuguese Network on Extracellular Vesicles, Portugal
|
2023 | STSM Grant, from COST Action CA20140 CorEuStem, for Catarina Trigo, in the scope of the project: "Differentiation of iPSC
to stellate cells, macrophages and hepatocyte-like cells". IDIBAPs (Lab head: Pau Sancho - Bru), Barcelona, Spain.
Cost Action CA20140 CorEuStem, Bélgica
|
2023 | STSM Grant, from COST Action CA20121 BenBedPhar, for Joana Rodrigues, in the scope of the project: "Unravelling the role of
Nrf2 in hepatic insulin resistance". Karolinska Institutet (Lab Head: Prof. Jorge Ruas), Stockholm, Sweden.
Cost Action 20121 BenBedPhar, Bélgica
|
2023 | Conference bursary for attendance at the ETRS & SPCE-TC Joint Meeting 2023, Coimbra, Portugal. The awarded abstract was: "IFN-gamma
and TNF-a preconditioning enhances the MSC's immunosuppressive and tissue regenerative abilities".
Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC), Portugal
|
2023 | Conference bursary for attendance at the ETRS & SPCE-TC Joint Meeting 2023, Coimbra, Portugal. The awarded abstract was: "Hepatic
SOS signals preconditioning modulate MSC-secretome and derived exosomes towards a more pro-regenerative abilities".
Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC), Portugal
|
2023 | Conference bursary for attendance at the ETRS & SPCE-TC Joint Meeting 2023, Coimbra, Portugal. The awarded abstract was: "Preconditioning
mesenchymal stem cells with IFN-gamma enhances their neuroregeneration and immunomodulatory properties".
Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC), Portugal
|
2023 | SPF Bursary to attend the EUROTOX 2023 - 57th Congress, Ljubljana, SI. Awarded abstract: "Exosomes derived from mesenchymal
stem cells exposed to hepatic injury signals reveal a distinct protein signature associated to pro-regenerative effects".
Portuguese Society of Pharmacology (SPF), Portugal
|
2022 | STSM Grant, from COST Action CA17112 Pro-EuroDILI, for Ana Sofia Serras, in the scope of the project: "Priming hnMSCs - secretome
for liver injury: The role on DILI immune response". IBIMA (Lab head: Prof. M. Isabel Lucena), University of Málaga, Spain.
COST Action CA17112 Pro-EuroDILI, Bélgica
|
2022 | EPAA 3Rs Student grant for the attendance of Joana Rodrigues in ICT2022, Maastricht, NL. Project entitled of: "Designing a
liver-on-a-chip to maintain stem cell-derived hepatocyte-like cells for toxicological analysis in vitro".
European Commission, Bélgica
|
2022 | ITC Grant, from Cost Action CA17112 Pro-EuroDILI, for the attendence of Ana Sofia Serras in ICT 2022, Maastricht, NL. Work
intitled of: "Exosomes derived from primed mesenchymal stem cells improve cell viability on an APAP-induced hepatic in vitro
model".
COST Action CA17112 Pro-EuroDILI, Bélgica
|
2022 | ITC Grant, from Cost Action CA17112 Pro-EuroDILI, for the attendance of Joana Rodrigues in ICT 2022, Maastricht, NL. Work
entitled of: "Designing a liver-on-a-chip to maintain stem cell-derived hepatocyte-like cells for toxicological analysis in
vitro".
COST Action CA17112 Pro-EuroDILI, Bélgica
|
2022 | EUROTOX 2022 travel and registration bursaries for Joana Rodrigues to participate in ICT 2022, Maastricht, NL. Work entitled
of: "Designing a liver-on-a-chip to maintain stem cell-derived hepatocyte-like cells for toxicological analysis in vitro".
European Society of Toxicology (EUROTOX), Bélgica
|
2022 | Erasmus+ Staff Mobility Grant for Training (STT) - Participation in the Annual Conference of the European Association of Faculties
of Pharmacy (EAFP2022), Valetta, Malta
European Commission, Bélgica
|
2021 | ITC Grant, from Cost Action CA16119 CellFit, for the participation of Ana Sofia Serras in the Summer School entitled of "Basics
to Work with Extracellular Vesicles". Centre of Translational Medicine - University of Tartu, Estonia.
Cost Action CA16119 CellFit, Bélgica
|
2021 | EUROTOX 2021 registration bursery for Ana Serras to participate in the 56th Congress of the European Societies of Toxicology.
Work entitled of: "The secretome of mesenchymal stem cells ameliorates the cytotoxic effects of doxorubicin in non-tumoral
cells"
European Society of Toxicology (EUROTOX), Bélgica
|
2019 | ITC Grant, from COST Action CA16113 CliniMARK, for attendance at the 55th Eurotox Congress, Helsinki, FI. The awarded work
was "Exploiting the exosomes from 3D cultures of human neonatal mesenchymal stem cells for the treatment of cutaneous wounds."
COST Action CA16113 CliniMARK, Bélgica
|
2019 | ITC Grant, from COST Action CA17112 Pro-EuroDILI, for attendance at the 55th Eurotox Congress, Helsinki, FI. The awarded work
was "Hepatocyte-like cells in microfluidic devices: a new platform for disease modelling."
COST Action CA17112 Pro-EuroDILI, Bélgica
|
2018 | Best oral communication: Exploring umbilical cord tissue-derived mesenchymal stem cells for the treatment of impaired wounds.
10th iMed.ULisboa Postgraduate Students Meeting & 3rd i3DU Meeting
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
2018 | Travel bursary for Sérgio Camões: Registration fee waiver for attendance at the 1st International Symposium Secretome With]Out[
Borders, Braga, PT.
Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC), Portugal
|
2017 | Registration bursary for the EMBO Conference “Advances in Stem Cells and Regenerative Medicine” for Sérgio Camões.
EMBO | EMBL Symposia, Alemanha
|
2017 | Registration bursary for the EMBO Conference “Advances in Stem Cells and Regenerative Medicine” for Joana Rodrigues.
EMBO | EMBL Symposia, Alemanha
|
2017 | Registration bursary for the Eurotox Congress 2017 for Sérgio Camões. Recruitment of bone marrow-derived mesenchymal stromal
cells by umbilical cord-derived mesenchymal stromal cells via G-CSF-mediated mechanism promotes wound healing in vivo. Bratislava
EUROTOX, Eslováquia
|
2017 | Registration bursary for the Eurotox Congress 2017 for Madalena Cipriano. 3D in vitro cultures of human Hepatocyte-Like Cells
as alternative competent model for nevirapine biotransformation. Bratislava
EMBO | EMBL Symposia, Alemanha
|
2016 | EUSAAT 2016 Young Scientist Travel Award for Madalena Cipriano. Self-Assembled 3D Spheroids of MSC-Derived Hepatocyte-Like
Cells for in vitro Toxicity Studies. 17th EUSAAT 2016 3Rs Congress, Austria, Linz
EUSAAT - European Society for Alternatives to Animal Testing, Áustria
|
2016 | Starting grant - FCT researcher (IF/00846/2015)
Fundação para a Ciência e a Tecnologia, Portugal
|
2015 | Terry Fox research grant in oncology by Liga Portuguesa Contra o Cancro. The award was to Pedro Pinheiro with the project
entitled Triggering a specific immune response against cancer – a strategy for primary and metastatic tumor treatment
Liga Portuguesa Contra o Cancro, Portugal
|
2015 | Best oral communication. The effect of epigenetic modifiers on the phenotype of hepatocyte-like cells derived from human neonatal
mesenchymal stem cells. 7th iMed.ULisboa Postgraduate Students Meeting, Lisbon, Portugal.
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
2015 | Best Poster award: Poster selection for oral communication. MSC crosstalk between UCX® and BM-MSCs involves G-CSF signalling
and promotes wound healing in vivo. 9th International Meeting of the Portuguese Society for Stem Cells (SPCE-TC), Oeiras,
PT
Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC), Portugal
|
2015 | Best Poster award: Selection for oral communication. 3D culture models for the maturation of stem cell derived hepatocyte-like
cells: spheroid culture and hollow fiber-bioreactor as potential in vitro alternatives for drug metabolism studies.
HeMiBio International Symposium, Bélgica
|
2015 | Travel bursary for the Eurotox Congress 2015 for Sérgio Camões. Human neonatal mesenchymal stem cell spheroids-conditioned
medium accelerates skin regeneration. Oporto, Portugal
EUROTOX 2015, Portugal
|
2015 | Travel bursary for the Eurotox Congress 2015 for Madalena Cipriano. Improvement of mesenchymal stromal cell differentiation
into hepatocyte-like cells using 3D culture models: Potential in vitro alternatives for drug metabolism studies. Oporto, PT
EUROTOX 2015, Portugal
|
2014 | Pod-doc grant (SFRH/BPD/96719/2013)
Fundação para a Ciência e a Tecnologia, Portugal
|
2013 | Research award. Sociedade Portuguesa de Estomatologia e Medicina Dentaria (SPEMD) on the study Effects off salivar acetylcholinesterase
on the cytotoxicity of acrylic reline resins.
Sociedade Portuguesa de Estomatologia e Medicina Dentaria (SPEMD), Portugal
|
2013 | Best abstract award. 3-D suspension cultures of umbilical cord-derived mesenchymal stromal cells (UCX®): preservation of mesenchymal
properties and potential for skin regeneration. 8th SPCE-TC, Faro, Portugal
Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC), Portugal
|
2012 | Poster award. Poster Efeito da Biodegradação na Citotoxicidade de Resinas Acrílicas de Rebasamento.
Sociedade Portuguesa de Estomatologia e Medicina Dentaria (SPEMD), Portugal
|
2009 | Ciência2008 Individual Grant
Fundação para a Ciência e a Tecnologia, Portugal
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Portugal |
2006 | Pos-doc grant (SFRH/BPD/26623/2006)
Fundação para a Ciência e a Tecnologia, Portugal
|
2001 | PhD scholarship (SFRH/BD/6494/2001)
Fundação para a Ciência e a Tecnologia, Portugal
|
Título
2017 | ERT (European Registered Toxicologist)
EUROTOX, Bélgica
|
2006 | PhD
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2000 | University Degree
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
Outra distinção
2019 | Top 5 at AstraZeneca Award for Innovation. EUROTOX, Helsinki, Finland. September, 2019. The awarded work was Hepatocyte-like
cells in microfluidic devices: a new platform for disease modelling.
EUROTOX 2019, Finlândia
|
2013 | Poster selection for oral communication: 3D hepatocyte cultures: a useful tool in the study of Nevirapine bioactivation and
toxicity. EUROTOX 2013 (49th Congress of the European Societies of Toxicology), Interlaken, Switzerland
EUROTOX 2013, Suiça
|